scholarly journals To evaluate the effect of combining photo-activation therapy with platelet-rich plasma injections for the novel treatment of osteoarthritis

2013 ◽  
Vol 2013 (mar26 1) ◽  
pp. bcr2012007463-bcr2012007463 ◽  
Author(s):  
J. B. Freitag ◽  
A. Barnard
Keyword(s):  
Platelet Rich Plasma ◽  
The Novel ◽  
Novel Treatment ◽  
Activation Therapy

scholarly journals PLATELET RICH PLASMA AS A NOVEL TREATMENT FOR CARPAL TUNNEL SYNDROME

2019 ◽  
Vol 25 (1) ◽  
pp. 110-115
Author(s):  
Esam Atwa ◽  
Asmaa Hosny Esh ◽  
Ibrahim Abd El Al ◽  
Yasmin Awad
Keyword(s):  
Carpal Tunnel Syndrome ◽  
Carpal Tunnel ◽  
Platelet Rich Plasma ◽  
Novel Treatment ◽  
Tunnel Syndrome

scholarly journals New Treatment Strategy for a Delayed Skin Necrosis Related to a Calcaneal Fracture

2017 ◽  
Vol 11 (1) ◽  
pp. 1568-1576 ◽  
Author(s):  
Konstantinos C. Xarchas ◽  
George Kyriakopoulos ◽  
Maria Vlachou ◽  
Katerina Manta
Keyword(s):  
Treatment Strategy ◽  
Skin Necrosis ◽  
Platelet Rich Plasma ◽  
Calcaneal Fracture ◽  
Treatment Modalities ◽  
Vacuum Assisted Closure ◽  
Avulsion Fractures ◽  
Novel Treatment ◽  
New Treatment ◽  
Skin Healing

In calcaneal avulsion fractures, skin necrosis as a result of pressure from the underlying fragment is a fairly common and serious complication. In spite of proper treatment, skin healing complication may occur. We report a calcaneal fracture case complicated by skin necrosis and managed with a novel treatment strategy including application of Platelet Rich Plasma (PRP) and Vacuum Assisted Closure (VAC). This is the first application of combined PRP and VAC treatment in a calcaneal fracture complicated by skin necrosis and was accompanied with very favorable outcomes while avoiding other more complex treatment modalities.

scholarly journals Development of Immunopathogenesis Strategies to Treat Behçet’s Disease

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Osman Köse
Keyword(s):  
Molecular Structure ◽  
Biologic Agents ◽  
Treatment Modalities ◽  
The Novel ◽  
Therapeutic Modalities ◽  
Novel Treatment ◽  
Unclear Etiology ◽  
Antigen Presenting ◽  
Disease Understanding ◽  
Novel Therapeutic

Behçet disease is a chronic relapsing vasculitis with unclear etiology and immunopathogenesis. Antigenic stimuli, antigen presenting cells, T cells, monocyte, and neutrophil and endothelial cells are major parts of the pathology of the disease. Understanding of the new pathogenic mechanisms based on molecular structure of the disease helps us in improving the novel therapeutic modalities. These drugs target specific and nonspecific inhibition of the immun system. These therapies include biologic agents, new topical and systemic immunosuppressants, tolerizing agents, and immunoablation. Novel treatment will be promising to treat the especially recalcitrant cases to conventional therapy. In this paper, new aspect of the immunopathogenesis of Behçet’s diseases and novel treatment modalities will be discussed.

scholarly journals Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

2019 ◽  
Vol 21 (1) ◽  
Author(s):  
Tomoaki Higuchi ◽  
Kae Takagi ◽  
Akiko Tochimoto ◽  
Yuki Ichimura ◽  
Takanari Norose ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Phosphatidic Acid ◽  
The Novel ◽  
Novel Treatment ◽  
Cyclic Phosphatidic Acid
Sign in / Sign up

Export Citation Format

Share Document